An analysis of patient-reported outcomes (PROs) from the SURPASS-SWITCH trial found that adults with type 2 diabetes who ...
Please provide your email address to receive an email when new articles are posted on . In business, the focus on consistent outcomes includes managing “inputs,” such as uniform materials and ...
Providing the best patient-centered care, as measured by the individual patient's perceived value of care at a reasonable cost, has become the established definition of value-based health care (VBHC).
Please provide your email address to receive an email when new articles are posted on . Historically, patient-reported outcome measures were primarily used for research. Today, surgeons use ...
Financial Distress in Genitourinary Cancer: Insights From CDC National Health Interview Survey Patient-reported outcomes (PROs) information has been routinely collected in Cancer Care Alberta (CCA) ...
Patient-reported outcome measures utilising a symptom questionnaire do not appear to expedite how quickly diagnosed depression symptoms dissipate nor do they improve overall social functioning or ...
This controlled trial randomly assigned patients with breast and prostate cancer undergoing treatment to complete one of three PRO measures: European Organisation for Research and Treatment of Cancer ...
Patient-reported outcomes (PROs) have rapidly become integral to cancer care, offering invaluable insights by capturing the patient’s perspective on symptoms, quality of life, and treatment-related ...
GP empathy assessed using the Consultation and Relational Empathy (CARE) Measure was correlated with improved patient enablement, greater satisfaction, and improvement in symptoms in telephone ...
This is a preview. Log in through your library . Abstract Purpose Patient-reported outcome measures (PROMs) are standardized instruments used to collect data about the subjective assessment of medical ...
SAN DIEGO, June 2, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced new data from the Phase 4 KINECT-PROTM open-label study demonstrating robust and sustained ...
An analysis of patient-reported outcomes (PROs) from the SURPASS-SWITCH trial found that adults with type 2 diabetes who switched from dulaglutide to tirzepatide not only saw stronger improvements in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results